CM

Chaitanya Matanhelia

Active Director Designated Partner DIN 10211609
DIN 10211609 First appointment Jun 2023 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Chaitanya Matanhelia

Data last updated:

Chaitanya Matanhelia is a Designated Partner at C Square Medco Llp (since 2023). The company operates in Healthcare.

DIN 10211609
Primary Designation Designated Partner
Industry Healthcare
First Appointment 23 Jun 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner23 Jun 20232023Active

Board colleagues of Chaitanya Matanhelia

NameDINCompanyDesignation
Chanda Matanhelia10211607C Square Medco LlpDesignated Partner
Gaurangee Matanhelia10211608C Square Medco LlpDesignated Partner

Directorship timeline

Open interactive timeline →
C Square Medco Llp
Premium access

Shareholding and investment profile for Chaitanya Matanhelia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chaitanya Matanhelia

Chaitanya Matanhelia currently holds 1 directorship: C Square Medco Llp (Designated Partner, since 23 Jun 2023).

Chaitanya Matanhelia was first appointed on 23 Jun 2023 as Designated Partner at C Square Medco Llp.

The current boards of Chaitanya Matanhelia's companies include Chanda Matanhelia (C Square Medco Llp), Gaurangee Matanhelia (C Square Medco Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available